ADMA Biologics Inc logo

ADMA Biologics Inc

NAS:ADMA (USA)   Ordinary Shares
$ 6.27 +0.07 (+1.13%) 10:08 PM EST
At Loss
P/B:
10.45
Volume:
3.24M
Avg Vol (2M):
2.76M
Volume:
3.24M
At Loss
Avg Vol (2M):
2.76M

Business Description

ADMA Biologics Inc logo
ADMA Biologics Inc
NAICS : 325412 SIC : 2834
ISIN : US0008991046

Share Class Description:

ADMA: Ordinary Shares
Description
ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.36
Equity-to-Asset 0.41
Debt-to-Equity 1.05
Debt-to-EBITDA 27.62
Interest Coverage 0.86
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.8
Distress
Grey
Safe
Beneish M-Score -2.14
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 60.08
9-Day RSI 54.38
14-Day RSI 54.26
6-1 Month Momentum % 96.51
12-1 Month Momentum % 78.9

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.16
Quick Ratio 1.69
Cash Ratio 1.03
Days Inventory 355.81
Days Sales Outstanding 38.87
Days Payable 27.94

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -29.2
Shareholder Yield % 0.05

Financials (Next Earnings Date:2024-05-10 Est.)

ADMA's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ADMA

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ADMA Biologics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 258.216
EPS (TTM) ($) -0.13
Beta 0.58
Volatility % 42.64
14-Day RSI 54.26
14-Day ATR ($) 0.230286
20-Day SMA ($) 6.289
12-1 Month Momentum % 78.9
52-Week Range ($) 3.06 - 6.76
Shares Outstanding (Mil) 231.77

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ADMA Biologics Inc Filings

Filing Date Document Date Form
No Filing Data

ADMA Biologics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

ADMA Biologics Inc Frequently Asked Questions

What is ADMA Biologics Inc(ADMA)'s stock price today?
The current price of ADMA is $6.27. The 52 week high of ADMA is $6.76 and 52 week low is $3.06.
When is next earnings date of ADMA Biologics Inc(ADMA)?
The next earnings date of ADMA Biologics Inc(ADMA) is 2024-05-10 Est..
Does ADMA Biologics Inc(ADMA) pay dividends? If so, how much?
ADMA Biologics Inc(ADMA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1